© 2020 MJH Life Sciences and Medical Economics. All rights reserved.
Study suggests all adults age 18 and older should be screened for HCV.
Shorter treatment could significantly reduce costs of therapy.
Effective direct-acting antivirals are available for teens.
Strong evidence supports removal of restrictions to direct-acting antiviral therapy based on recent drug use.